Home > Healthcare > Medical Devices > Therapeutic Devices > Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market Share

Report ID: GMI6323
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Radiofrequency Ablation Devices Market Share

Some of the prominent radiofrequency ablation devices market participants operating in the radiofrequency ablation devices industry include

Avanos Medical, Inc.
Stryker Corporation
Abbott Laboratories, Inc.
Medtronic, Plc.
Boston Scientific Corporation
Becton
Dickinson and Company (Venclose, Inc.)
AngioDynamics, Inc.
Hologic, Inc.
AtriCure, Inc.
Koninklijke Philips N.V., Smith & Nephew
Baylis Medical Company, Inc
inomed Medizintechnik GmbH
Sutter Medizintechnik GmbH
Epimed International

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Radiofrequency ablation devices market size reached USD 4.3 billion in 2022 and will record USD 10.4 billion by 2032 due to the increasing prevalence of chronic diseases, growing demand for minimally invasive treatments and higher advancements in medical technology

The hospitals segment is predicted to observe 9.3% CAGR from 2023-2032 owing to advantages, such as shorter hospital stays, faster patient recovery, and reduced risk of complications.

U.S. industry size was USD 1.6 billion in revenue size in 2022 and is predicted to witness substantial market growth through 2032 owing to the growing prevalence of chronic diseases such as cancer, diabetes and cardiovascular conditions

Some of the major radiofrequency ablation device providers include Avanos Medical, Inc., Stryker Corporation, Abbott Laboratories, Inc., Medtronic, Plc., Boston Scientific Corporation, Becton, Dickinson and Company (Venclose, Inc.), AngioDynamics, Inc., Hologic, Inc., and AtriCure, Inc.,